Abstract
Lowering of thyroid-stimulating hormone (TSH) cutoffs in newborn screening programs has created a management dilemma by leading to more frequent detection of neonates with elevated TSH concentrations due to false-positive results, transient neonatal hyperthyrotropinemia (NHT), and milder forms of congenital hypothyroidism. Current consensus guidelines recommend starting treatment if the venous TSH level is >20 mU/L in the face of a normal free thyroxine (FT4) level, which is an arbitrary threshold for treatment decisions. In countries such as Türkiye, where transient NHT may be more common due to iodine deficiency (ID) and/or overload, putting this recommendation into daily practice may lead to unnecessary or over treatment, time-consuming long-term follow-up, and increased workload and costs. In this review, we addressed alternative approaches for infants with elevated TSH concentrations detected at newborn screening. The suggested management approach can be summarized as: Infants with mild NHT (venous TSH <20 mU/L) should be followed without treatment. In moderate NHT (venous TSH 20-30 mU/L), treatment or monitoring decisions can be made according to age, TSH trend and absolute FT4 level. Moderate cases of NHT should be treated if age at confirmatory testing is >21 days or if there is no downward trend in TSH and FT4 level is in the lower half of age-specific reference range in the first 21 days. In in-between cases of moderate NHT, thyroid ultrasound may guide treatment decision by determining mild cases of thyroid dysgenesis that require life-long treatment. Otherwise, monitoring is a reasonable option. Infants with compensated hypothyroidism (venous TSH >30 mU/L and normal FT4) or persistent hyperthyrotropinemia (>6-10 mU/L after the neonatal period) should receive L-thyroxine treatment. However, all treated cases of isolated TSH elevation should be closely monitored to avoid overtreatment, and re-evaluated by a trial off therapy. This alternative approach will largely eliminate unnecessary treatment of infants with transient NHT, mostly caused by ID or excess in Türkiye, and will reduce workload and costs by preventing unwarranted investigation and long-term follow-up.
Keywords: Congenital hypothyroidism, neonatal hyperthyrotropinemia, newborn screening
Read the full text
2 sections · 1 figure · 4 tables · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010;5:17.
Peters C, van Trotsenburg ASP, Schoenmakers N. Diagnosis of endocrine disease: congenital hypothyroidism: update and perspectives. Eur J Endocrinol. 2018;179:297-317.
Tenenbaum-Rakover Y, Almashanu S, Hess O, Admoni O, Hag-Dahood Mahameed A, Schwartz N, Allon-Shalev S, Bercovich D, Refetoff S. Long-term outcome of loss-of-function mutations in thyrotropin receptor gene. Thyroid. 2015;25:292-299. Epub 2015 Jan 28.
Vigone MC, Di Frenna M, Guizzardi F, Gelmini G, de Filippis T, Mora S, Caiulo S, Sonnino M, Bonomi M, Persani L, Weber G. Mild TSH resistance: clinical and hormonal features in childhood and adulthood. Clin Endocrinol (Oxf). 2017;87:587-596. Epub 2017 Jul 6.
Persani L. Clinical review: central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab. 2012;97:3068-3078. Epub 2012 Jul 31.
Radwin LS, Michelson JP, Berman AB, Kramer, B. End results in treatment of congenital hypothyroidism; follow-up study of physical, mental and behavioral development. Am J Dis Child. 1949;78:821-843.
Klein AH, Meltzer S, Kenny FM. Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr. 1972;81:912-915.
Klein AH, Agustin AV, Foley TP Jr. Successful laboratory screening for congenital hypothyroidism. Lancet. 1974;13;2:77-79.
Dussault JH, Laberge C. Dosage de la thyroxine (T4) par méthode radio-immunologique dans l’éluat de sang séché: nouvelle méthode de dépistage de l’hypothyroïdie néonatale? [Thyroxine (T4) determination by radioimmunological method in dried blood eluate: new diagnostic method of neonatal hypothyroidism?]. Union Med Can. 1973;102:2062-2064.
Dussault JH. The anecdotal history of screening for congenital hypothyroidism. J Clin Endocrinol Metab. 1999;84:4332-4334.
Fisher DA, Dussault JH, Foley TP Jr, Klein AH, LaFranchi S, Larsen PR, Mitchell ML, Murphey WH, Walfish PG. Screening for congenital hypothyroidism: results of screening one million North American infants. J Pediatr. 1979;94:700-705.
Salerno M, Capalbo D, Cerbone M, De Luca F. Subclinical hypothyroidism in childhood - current knowledge and open issues. Nat Rev Endocrinol. 2016;12:734-746. Epub 2016 Jul 1.
Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014;3:76-94. Epub 2014 Jun 7.
Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, Polak M, Butler G; ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE; Congenital Hypothyroidism Consensus Conference Group. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm Res Paediatr. 2014;81:80-103. Epub 2014 Jan 21.
van Trotsenburg P, Stoupa A, Léger J, Rohrer T, Peters C, Fugazzola L, Cassio A, Heinrichs C, Beauloye V, Pohlenz J, Rodien P, Coutant R, Szinnai G, Murray P, Bartés B, Luton D, Salerno M, de Sanctis L, Vigone M, Krude H, Persani L, Polak M. Congenital hypothyroidism: a 2020-2021 Consensus Guidelines update-an ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid. 2021;31:387-419.
Rose SR, Wassner AJ, Wintergerst KA, Yayah-Jones NH, Hopkin RJ, Chuang J, Smith JR, Abell K, LaFranchi SH; Section on Endocrinology Executive Committee; Council on Genetics Executive Committee. Congenital hypothyroidism: screening and management. Pediatrics. 2023;151:2022060419.
Grüters A, Krude H. Detection and treatment of congenital hypothyroidism. Nat Rev Endocrinol. 2011;8:104-113.
Van Vliet G, Deladoëy J. Interpreting minor variations in thyroid function or echostructure: treating patients, not numbers or images. Pediatr Clin North Am. 2015;62:929-942. Epub 2015 Jun 24.
Chiesa AE, Tellechea ML. Update on neonatal isolated hyperthyrotropinemia: a systematic review. Front Endocrinol (Lausanne). 2021;12:643307.
Özon A, Tekin N, Şıklar Z, Gülcan H, Kara C, Taştekin A, Demir K, Koç E, Evliyaoğlu O, Kurtoğlu S. Neonatal effects of thyroid diseases in pregnancy and approach to the infant with increased TSH: Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report. Turk Pediatri Ars. 2018;53:209-223.
Demirel F, Bideci A, Camurdan MO, Cinaz P. L-thyroxin treatment in infants with hyperthyrotropinaemia: 4-year experience. Int J Clin Pract. 2007;61:1333-1336.
Deladoëy J, Ruel J, Giguère Y, Van Vliet G. Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective population-based study in Québec. J Clin Endocrinol Metab. 2011;96:2422-2429. Epub 2011 Jun 1.
Oren A, Wang MK, Brnjac L, Mahmud FH, Palmert MR. Mild neonatal hyperthyrotrophinaemia: 10-year experience suggests the condition is increasingly common but often transient. Clin Endocrinol (Oxf). 2013;79:832-837. Epub 2013 May 27.
Evliyaoğlu O, Kutlu A, Kara C, Atavci SG. Incidence of iodine deficiency in Turkish patients with congenital hypothyroidism. Pediatr Int. 2008;50:276-280.
Oguz Kutlu A, Kara C. Iodine deficiency in pregnant women in the apparently iodine-sufficient capital city of Turkey. Clin Endocrinol (Oxf). 2012;77:615-620.
Yaman AK, Demirel F, Ermiş B, Pişkin IE. Maternal and neonatal urinary iodine status and its effect on neonatal TSH levels in a mildly iodine-deficient area. J Clin Res Pediatr Endocrinol. 2013;5:90-94.
Kara C, Günindi F, Can Yılmaz G, Aydın M. Transient congenital hypothyroidism in Turkey: an analysis on frequency and natural course. J Clin Res Pediatr Endocrinol. 2016;8:170-179. Epub 2016 Apr 18.
Vural M, Koc E, Evliyaoglu O, Acar HC, Aydin AF, Kucukgergin C, Apaydin G, Erginoz E, Babazade X, Sharifova S, Perk Y; Turkish Iodine Survey Group. Iodine status of Turkish pregnant women and their offspring: a national cross-sectional survey. J Trace Elem Med Biol. 2021;63:126664 Epub 2020 Oct 7.
Özer Y, Anık A, Sayılı U, Tercan U, Deveci Sevim R, Güneş S, Buhur Pirimoğlu M, Elmaoğulları S, Dündar I, Ökdemir D, Besci Ö, Jalilova A, Çiçek D, Singin B, Ulu ŞE, Turan H, Albayrak S, Kocabey Sütçü Z, Eklioğlu BS, Eren E, Çetinkaya S, Savaş-Erdeve Ş, Esen I, Demir K, Darcan Ş, Hatipoğlu N, Parlak M, Dursun F, Şıklar Z, Berberoğlu M, Keskin M, Orbak Z, Tezel B, Yürüker E, Keskinkılıç B, Kara F, Erginöz E, Darendeliler F, Evliyaoğlu O. High frequency of transient congenital hypothyroidism among infants referred for suspected congenital hypothyroidism from the Turkish National screening program: thyroxine dose may guide the prediction of transients. J Endocrinol Invest. 2024;47:2213-2224.
Dilli D, Ozbaş S, Acıcan D, Yamak N, Ertek M, Dilmen U. Establishment and development of a national newborn screening programme for congenital hypothyroidism in Turkey. J Clin Res Pediatr Endocrinol. 2013;5:73-79.
Çaylan N, Tezel B, Özbaş S, Şahin N, Aydın Ş, Acıcan D, Keskinkılıç B. Neonatal thyroid-stimulating hormone screening as a monitoring tool for iodine deficiency in Turkey. J Clin Res Pediatr Endocrinol. 2016;8:187-191. Epub 2016 Apr 18.
Yordam N, Calikoğlu AS, Hatun S, Kandemir N, Oğuz H, Teziç T, Ozalp I. Screening for congenital hypothyroidism in Turkey. Eur J Pediatr. 1995;154:614-616.
Yordam N, Ozön A, Alikaşifoğlu A, Ozgen A, Ceren N, Zafer Y, Simşek E. Iodine deficiency in Turkey. Eur J Pediatr. 1999;158:501-505.
Erdoğan G, Erdoğan MF, Delange F, Sav H, Güllü S, Kamel N. Moderate to severe iodine deficiency in three endemic goitre areas from the Black Sea region and the capital of Turkey. Eur J Epidemiol. 2000;16:1131-1134.
Erdoğan G, Erdoğan MF, Emral R, Baştemir M, Sav H, Haznedaroğlu D, Ustündağ M, Köse R, Kamel N, Genç Y. Iodine status and goiter prevalence in Turkey before mandatory iodization. J Endocrinol Invest. 2002;25:224-228.
Kurtoglu S, Akcakus M, Kocaoglu C, Gunes T, Budak N, Atabek ME, Karakucuk I, Delange F. Iodine status remains critical in mother and infant in Central Anatolia (Kayseri) of Turkey. Eur J Nutr. 2004;43:297-303. Epub 2004 Jan 30.
Sağlam H, Büyükuysal L, Köksal N, Ercan I, Tarim O. Increased incidence of congenital hypothyroidism due to iodine deficiency. Pediatr Int. 2007;49:76-79.
Kut A, Gursoy A, Senbayram S, Bayraktar N, Budakoğlu II, Akgün HS. Iodine intake is still inadequate among pregnant women eight years after mandatory iodination of salt in Turkey. J Endocrinol Invest. 2010;33:461-464. Epub 2009 Dec 22.
Erdoğan MF, Ağbaht K, Altunsu T, Ozbaş S, Yücesan F, Tezel B, Sargin C, Ilbeğ I, Artik N, Köse R, Erdoğan G. Current iodine status in Turkey. J Endocrinol Invest. 2009;32:617-622. Epub 2009 Jun 24.
Egri M, Ercan C, Karaoglu L. Iodine deficiency in pregnant women in eastern Turkey (Malatya Province): 7 years after the introduction of mandatory table salt iodization. Public Health Nutr. 2009;12:849-852. Epub 2008 Jul 29.
Celik H, Guldiken S, Celik O, Taymez F, Dagdeviren N, Tuğrul A. Iodine deficiency in pregnant women living in Western Turkey (Edirne). Acta Endocrinol (Buchar). 2016;12:14-18.
Oral E, Aydogan Mathyk B, Aydogan BI, Acıkgoz AS, Erenel H, Celik Acıoglu H, Anık Ilhan G, Dane B, Ozel A, Tandogan B, Cakar E, Isci H, Kayan B, Aslan H, Ekiz A, Sancak S, Celik A, Yoldemir T, Uzun O, Erdogan MF. Iodine status of pregnant women in a metropolitan city which proved to be an iodine-sufficient area. Is mandatory salt iodisation enough for pregnant women? Gynecol Endocrinol. 2016;32:188-192.
Anaforoğlu İ, Algün E, İnceçayır Ö, Topbaş M, Erdoğan MF. Iodine status among pregnant women after mandatory salt iodisation. Br J Nutr. 2016;115:405-410. Epub 2015 Nov 24.
Çelmeli G, Çürek Y, Özen Küçükçetin İ, Arslan Gülten Z, Özdem S, Akçurin S, Bircan İ. The results of 16 years of iodization: assessment of iodine deficiency among school-age children in Antalya, Turkey. J Clin Res Pediatr Endocrinol. 2020;12:256-260.
World Health Organization. International Council for Control of Iodine Deficiency Disorders & United Nations Children’s Fund (UNICEF). Indicators for assessing iodine deficiency disorders and their control through salt iodization. 1994. Last Accessed Date: 04.07.2025. Available from: https://iris.who.int/handle/10665/70715
World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers, 3rd ed. 2007. Last Accessed Date: 04.07.2025. Available from: https://iris.who.int/handle/10665/43781
World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Cardiovascular Risk. Geneva, 2007;1-86. Last Accessed Date: 04.07.2025. Available from: https://iris.who.int/bitstream/handle/10665/43685/9789241547178_eng.pdf?sequence=1
Public Health Committee of the American Thyroid Association; Becker DV, Braverman LE, Delange F, Dunn JT, Franklyn JA, Hollowell JG, Lamm SH, Mitchell ML, Pearce E, Robbins J, Rovet JF. Iodine supplementation for pregnancy and lactation-United States and Canada: recommendations of the American Thyroid Association. Thyroid. 2006;16:949-951.
Parks JS, Lin M, Grosse SD, Hinton CF, Drummond-Borg M, Borgfeld L, Sullivan KM. The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics. 2010;125:54-63.
Ford G, LaFranchi SH. Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pract Res Clin Endocrinol Metab. 2014;28:175-187. Epub 2013 Jun 18.
Pearce MS, Korada M, Day J, Turner S, Allison D, Kibirige M, Cheetham TD. Increasing incidence, but lack of seasonality, of elevated TSH levels, on newborn screening, in the north of England. J Thyroid Res. 2010;2010:101948.
Mitchell ML, Hsu HW, Sahai I; Massachusetts Pediatric Endocrine Work Group. The increased incidence of congenital hypothyroidism: fact or fancy? Clin Endocrinol (Oxf). 2011;75:806-810.
Olivieri A, Fazzini C, Medda E; Italian Study Group for Congenital Hypothyroidism. Multiple factors influencing the incidence of congenital hypothyroidism detected by neonatal screening. Horm Res Paediatr. 2015;83:86-93. Epub 2015 Jan 6.
Wassner AJ. Congenital hypothyroidism. Clin Perinatol. 2018;45:1-18.
Asena M, Demiral M, Unal E, Öcal M, Demirbilek H, Özbek MN. Validity of six month l-thyroxine dose for differentiation of transient or permanent congenital hypothyroidism. J Clin Res Pediatr Endocrinol. 2020;12:275-280. Epub 2020 Jan 28.
Connelly KJ, LaFranchi SH. Detection of neonates with mild congenital hypothyroidism (primary) or isolated hyperthyrotropinemia: an increasingly common management dilemma. Expert Rev Endocrinol Metab. 2014;9:263-271. Epub 2014 Mar 17.
Bongers-Schokking JJ, Resing WC, de Rijke YB, de Ridder MA, de Muinck Keizer-Schrama SM. Cognitive development in congenital hypothyroidism: is overtreatment a greater threat than undertreatment? J Clin Endocrinol Metab. 2013;98:4499-4506. Epub 2013 Aug 26.
Lain S, Trumpff C, Grosse SD, Olivieri A, Van Vliet G. Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted? Eur J Endocrinol. 2017;177(5):D1-D12. Epub 2017 Jul 10.
Fyrö K, Bodegård G. Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism. Acta Paediatr Scand. 1987;76:107-114.
Cuestas E, Gaido MI, Capra RH. Transient neonatal hyperthyrotropinemia is a risk factor for developing persistent hyperthyrotropinemia in childhood with repercussion on developmental status. Eur J Endocrinol. 2015;172:483-490. Epub 2015 Jan 20.
Lain SJ, Bentley JP, Wiley V, Roberts CL, Jack M, Wilcken B, Nassar N. Association between borderline neonatal thyroid-stimulating hormone concentrations and educational and developmental outcomes: a population-based record-linkage study. Lancet Diabetes Endocrinol. 2016;4:756-765. Epub 2016 Jul 22.
Trumpff C, De Schepper J, Vanderfaeillie J, Vercruysse N, Van Oyen H, Moreno-Reyes R, Tafforeau J, Vandevijvere S. Neonatal thyroid-stimulating hormone concentration and psychomotor development at preschool age. Arch Dis Child. 2016;101:1100-1106.
West R, Hong J, Derraik JGB, Webster D, Heather NL, Hofman PL. Newborn screening TSH values less than 15 mIU/L are not associated with long-term hypothyroidism or cognitive impairment. J Clin Endocrinol Metab. 2020;105:415.
Jaruratanasirikul S, Sangsupawanich P, Koranantakul O, Chanvitan P, Ruaengrairatanaroj P, Sriplung H, Patanasin T, Sukmee S. Maternal iodine status and neonatal thyroid-stimulating hormone concentration: a community survey in Songkhla, southern Thailand. Public Health Nutr. 2009;12:2279-2284. Epub 2009 Mar 12.
Sukkhojaiwaratkul D, Mahachoklertwattana P, Poomthavorn P, Panburana P, Chailurkit LO, Khlairit P, Pongratanakul S. Effects of maternal iodine supplementation during pregnancy and lactation on iodine status and neonatal thyroid-stimulating hormone. J Perinatol. 2014;34:594-598. Epub 2014 Apr 17.
Kara C. Konjenital hipotiroidizm. In: Çil E. (Ed.) Çocuklarda bulgulardan tanıya algoritmalar. [Congenital hypothyroidism. In: Çil E (Ed.) Algorithms from findings to diagnosis in children] İstanbul Tıp Kitabevleri: 2021.
Behura SS, Nikhila GP, Panda SK. Screening and management of congenital hypothyroidism - Guidelines by American Academy of Pediatrics, 2023. Indian Pediatr. 2023;60:855-858.
Sagsak E, Dagdeviren Cakır A, Ozer Y, Yesiltepe Mutlu G, Ozcabi B, Kara C; Thyroid Research Group. Attitudes towards the management of congenital hypothyroidism in Türkiye: national survey study. J Clin Res Pediatr Endocrinol. 2025.
Önsesveren I, Barjaktarovic M, Chaker L, de Rijke YB, Jaddoe VWV, van Santen HM, Visser TJ, Peeters RP, Korevaar TIM. Childhood thyroid function reference ranges and determinants: a literature overview and a prospective cohort study. Thyroid. 2017;27:1360-1369. Epub 2017 Oct 24.
Iijima S. Current knowledge of transient hypothyroxinemia of prematurity: to treat or not to treat? J Matern Fetal Neonatal Med. 2019;32:2591-2597. Epub 2018 Feb 22.
Karakoc-Aydiner E, Turan S, Akpinar I, Dede F, Isguven P, Adal E, Guran T, Akcay T, Bereket A. Pitfalls in the diagnosis of thyroid dysgenesis by thyroid ultrasonography and scintigraphy. Eur J Endocrinol. 2012;166:43-48. Epub 2011 Oct 17.
Kara C, Mammadova J, Abur Ü, Gumuskaptan C, İzci Güllü E, Dağdemir A, Aydın M. Genetic testing can change diagnosis and treatment in children with congenital hypothyroidism. Eur Thyroid J. 2023;12:220212.
Fisher DA, Nelson JC, Carlton EI, Wilcox RB. Maturation of human hypothalamic-pituitary-thyroid function and control. Thyroid. 2000;10:229-234.
Leonardi D, Polizzotti N, Carta A, Gelsomino R, Sava L, Vigneri R, Calaciura F. Longitudinal study of thyroid function in children with mild hyperthyrotropinemia at neonatal screening for congenital hypothyroidism. J Clin Endocrinol Metab. 2008;93:2679-2685. Epub 2008 Apr 29.
Zung A, Tenenbaum-Rakover Y, Barkan S, Hanukoglu A, Hershkovitz E, Pinhas-Hamiel O, Bistritzer T, Zadik Z. Neonatal hyperthyrotropinemia: population characteristics, diagnosis, management and outcome after cessation of therapy. Clin Endocrinol (Oxf). 2010;72:264-271. Epub 2009 May 18.
De Sanctis V, Soliman AT, Di Maio S, Elsedfy H, Soliman NA, Elalaily R. Thyroid hemiagenesis from childhood to adulthood: review of literature and personal experience. Pediatr Endocrinol Rev. 2016;13:612-619.
Eugster EA, LeMay D, Zerin JM, Pescovitz OH. Definitive diagnosis in children with congenital hypothyroidism. J Pediatr. 2004;144:643-647.
Rabbiosi S, Vigone MC, Cortinovis F, Zamproni I, Fugazzola L, Persani L, Corbetta C, Chiumello G, Weber G. Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J Clin Endocrinol Metab. 2013;98:1395-1402. Epub 2013 Feb 20.


